Heinz Dr. Hänel

Advisor at Mitodicure
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Oberursel, Hesse, Germany, DE

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Biotechnology Research
    • 1 - 100 Employee
    • Advisor
      • Jun 2023 - Present

  • Aprofol AG
    • Schaffhausen, Schweiz
    • Vorstandsmitglied
      • May 2023 - Present

    • Germany
    • Venture Capital and Private Equity Principals
    • 1 - 100 Employee
    • Investment committe
      • Jul 2022 - Present

    • Germany
    • Investment Banking
    • 1 - 100 Employee
    • Beiratsmitglied
      • Mar 2022 - Present

    • Switzerland
    • Medical Device
    • 700 & Above Employee
    • Advisor
      • Oct 2021 - Present

    • Germany
    • Business Consulting and Services
    • 100 - 200 Employee
    • Senior Academic Advisor
      • Oct 2021 - Present

    • Pharma Development
      • Sep 2021 - Present

      Sanofi-aventis Quality Global Quality and ComplianceQuality Product Expert Taxotere/Eloxatin 01/2005 to 10/2005Areas of work: Supporting any issue on quality and regulatory compliance of Taxotere and Eloxatin in all countries of the world. Co-leader of fighting generics. Training of users, prevention of recalls, improving quality performance in the manufacturing site. Support of the Eloxatin transfer to Dagenham.WHO/ Access to Medicine Program part time assignmentSince 2001 member of the steering committee for sleeping sickness with the WHO donation. Since 11/2004 work with Philippe Baetz on the Tuberculosis strategy (Rifampicin - BSE free - from Brindisi). Since April 2005 creation of a dossier on sleeping sickness for the strategy decisions of senior management on how to continue collaboration with the WHO. Launch of Fexinidazole in 2019. The WHO considers me the “father” of Fexinidazole.Sanofi-aventis Science and medical affairs SMA Since 2005 Project Director for the development of anti-diabetic compounds, Project director for PPAR’s, SGLT2, Lixisenatide and the Wellstat compound (PKC epsilon inhibitor) Global Project Director for Lantus, Apidra, and Insuman. Since 06 2012 in addition responsible for the China submissions of Lixisenatide and InsumanFrom 02 2015 to 01 2016 leading the project CURVE for a patch pump.Since 01 2014 leading the project “flexible bag”Since 2018 leading the project “once weekly insulin” Show less

    • Beratung bei der Entwicklung von neuen Arzneimitteln
      • Sep 2021 - Present

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Senior Berater
      • Aug 2021 - Present

    • France
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Projekt Direktor
      • Oct 1984 - Aug 2021

Education

  • Johann Wolfgang Goethe-Universität Frankfurt am Main
    Habilitation, Zoologie/Tierbiologie
    1976 - 1994
  • Universiti Kuala Lumpur
    Research Project
    1980 - 1981
  • University of Canberra
    Research Project, Entomology

Community

You need to have a working account to view this content. Click here to join now